We are live on ! Find out more
LABP

Landos Biopharma, Inc. Common Stock

Delisted

LABP was delisted on the 23rd of May, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
PA
1
Perceptive Advisors
New York
$4.43M
Macquarie Group
2
Macquarie Group
Australia
$44K
Geode Capital Management
3
Geode Capital Management
Massachusetts
$27.3K -$258 -70 -0.8%
Citadel Advisors
4
Citadel Advisors
Florida
$25.7K +$31.8K +8,609 New
Renaissance Technologies
5
Renaissance Technologies
New York
$24K -$17.1K -4,620 -37%
WAM
6
Warberg Asset Management
Illinois
$21.9K +$27.1K +7,350 New
BCM
7
Bridgeway Capital Management
Texas
$11.6K -$22.1K -6,000 -61%
BlackRock
8
BlackRock
New York
$10.1K +$3.48K +944 +39%
State Street
9
State Street
Massachusetts
$7.51K
Vanguard Group
10
Vanguard Group
Pennsylvania
$7.15K -$29.2K -7,909 -77%
TRCT
11
Tower Research Capital (TRC)
New York
$6K +$1.3K +352 +20%
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$4.46K -$2.24K -608 -29%
Northern Trust
13
Northern Trust
Illinois
$3.64K
SGCA
14
Steel Grove Capital Advisors
Tennessee
$2.98K -$31.2K -8,450 -89%
UBS Group
15
UBS Group
Switzerland
$1.87K +$2.18K +590 +1,553%
Wells Fargo
16
Wells Fargo
California
$32
Bank of America
17
Bank of America
North Carolina
$8 +$11 +3 New
HF
18
HRT Financial
New York
-$26K -5,256 Closed
Deutsche Bank
19
Deutsche Bank
Germany
-$20.9K -4,176 Closed
Jane Street
20
Jane Street
New York
-$7.41K -1,483 Closed
Fidelity Investments
21
Fidelity Investments
Massachusetts
-$1K -200 Closed
Morgan Stanley
22
Morgan Stanley
New York
-$384 -77 Closed
Citigroup
23
Citigroup
New York
-$260 -52 Closed
Royal Bank of Canada
24
Royal Bank of Canada
Ontario, Canada
-$103 -28 -74%